BUZZ — Drugmaker Liquidia rallies on United Therapeutics settlement

* Drugmaker Liquidia's shares up 46.21% at $39.20 premarket * Co says it settles all six pending lawsuits with United Therapeutics, ensuring uninterrupted access to YUTREPIA, a drug used to treat patients with a form of pulmonary hypertension * Co to pay a net $380.7 mln in instalments through 2027 to resolve the litigation * Stock down more than 22% YTD, as of last close (Reporting by Jayasree Prabhu) ((jayasree.prabhu@thomsonreuters.com)